98%
921
2 minutes
20
Tobacco smoke, a complex mixture of particulate matter (PM) and gaseous pollutants, poses serious health risks and remains a significant challenge for indoor air purification. Photocatalytic oxidation (PCO) technology has emerged as an effective strategy for pollutant removal, but its application in real tobacco smoke purification and associated health impacts remains underexplored. Herein, we investigated the simultaneous removal of PM and volatile organic compounds (VOCs) from tobacco smoke using a PCO purifier. The PCO purifier exhibited superior PM removal, achieving 99% efficiency within 10 min and reducing ultrafine PM concentrations to one-tenth of those observed with high efficiency particulate air (HEPA) filtration. The 63 main VOCs, predominantly oxygenated VOCs, were identified in tobacco smoke with the PCO purifier exhibiting over 99% removal efficiency within 300 min. Furthermore, the PCO purifier demonstrated exceptional stability and long-term durability across varying humidity levels and smoke concentrations. The hazard index (HI) was quantified to evaluate the health risks associated with tobacco smoke. The PCO purifier reduced HI by 95% within 120 min, demonstrating its effectiveness in mitigating exposure risks. Additionally, the major HI was primarily established from four key indicator compounds (i.e., 2,5-dimethylfuran, 2,3-butanedione, -nitrosomethylethylamine, and isocyanic acid), which reliably estimated the overall health risks during the purification of tobacco smoke. The study provides a promising strategy for the simultaneous purification of multiple pollutants from tobacco smoke in the indoor environment along with a convenient method for assessing the associated health impacts.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.est.5c01523 | DOI Listing |
J Bras Pneumol
September 2025
. Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo (SP) Brasil.
Objective: To describe the sociodemographic and clinical characteristics of individuals exposed to smoking or biomass smoke and followed at primary health care (PHC) centers across three states in Brazil.
Methods: This was a cross-sectional multicenter study including patients followed at any of four PHC centers in Brazil. Patients ≥ 35 years of age who were smokers or former smokers, or were exposed to biomass smoke were included, the exception being those with physical/mental disabilities and those who were pregnant.
Nicotine Tob Res
September 2025
Health Outcomes & Biomedical Informatics, University of Florida College of Medicine, Gainesville, FL, USA.
Introduction: Evidence-based interventions to reduce tobacco-related morbidity and mortality are not widely or effectively implemented, thereby failing to equitably address disparities in tobacco-related health outcomes. Implementation science (IS) has the potential to advance the impact of tobacco control programs, but its use in this field has not been previously explored. To identify opportunities for expanding tobacco intervention impact, this scoping review investigated the use of IS tools in tobacco control research in the United States.
View Article and Find Full Text PDFCancer
September 2025
Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Tobacco use is the primary contributor to disease and death in the United States, and cigarette smoking is the leading risk factor for lung cancer. Safe and effective treatments for tobacco dependence exist; however, access to and use of tobacco treatment remains low. The most recent Centers for Medicare and Medicaid Services National Coverage Determination requires a shared decision-making visit for lung cancer screening that includes counseling on the importance of maintaining cigarette smoking abstinence if a person formerly smoked; or the importance of smoking cessation if a person currently smokes and, if appropriate, furnishing of information about tobacco-cessation interventions.
View Article and Find Full Text PDFAm Heart J Plus
October 2025
Department of Medical Laboratory Science, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.
Introduction: Cigarette smoking is a well-recognized independent risk factor for numerous cardiovascular disorders and contributes to the increasing morbidity and mortality associated with chronic heart diseases (CHD). This study aimed to evaluate how cigarette smoking affects lipid metabolism and inflammatory processes, along with other related mechanisms, in order to better understand the potential cardiovascular risks faced by smokers.
Objectives: To evaluate and compare the serum lipid profile and high-sensitivity C-reactive protein levels between cigarette smokers and non-smokers.
Environ Epigenet
May 2025
Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institut pour l'Avancée des Biosciences (IAB), Team of Environmental Epidemiology Applied to Development and Respiratory Health, 38000 Grenoble, France.
An increasing number of epigenome-wide association studies report tobacco smoking-associated DNA methylation levels. However, comprehensive replication studies remain scarce, particularly in placenta, despite their crucial interest in such a large-scale context. Using DNA methylation data from the EPIC array of 341 new placentas (85 smokers, 219 non-smokers, and 37 former smokers) from the EDEN cohort, we used a candidate approach to replicate maternal smoking-associated CpGs and regions previously identified using the 450K array, and an exploratory approach to discover new associations within EPIC-specific CpGs.
View Article and Find Full Text PDF